C.UyemuraLtd（4966）株式概要上村商会は、子会社とともに、日本、台湾、中国および海外で、表面処理薬品および表面処理機械の研究、開発、製造、販売を行っています。 詳細4966 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長3/6過去の実績2/6財務の健全性6/6配当金3/6報酬当社が推定した公正価値より37.5%で取引されている 収益は年間14.36%増加すると予測されています リスク分析JP市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見る4966 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥23.44k22.4% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture0151b2016201920222025202620282031Revenue JP¥150.7bEarnings JP¥22.9bAdvancedSet Fair ValueView all narrativesC.Uyemura & Co.,Ltd. 競合他社DICSymbol: TSE:4631Market cap: JP¥438.1bKansai PaintSymbol: TSE:4613Market cap: JP¥412.3bFuso ChemicalLtdSymbol: TSE:4368Market cap: JP¥420.0bTokuyamaSymbol: TSE:4043Market cap: JP¥315.2b価格と性能株価の高値、安値、推移の概要C.UyemuraLtd過去の株価現在の株価JP¥23,430.0052週高値JP¥26,960.0052週安値JP¥8,480.00ベータ1.21ヶ月の変化1.78%3ヶ月変化10.99%1年変化156.07%3年間の変化243.05%5年間の変化453.90%IPOからの変化1,928.57%最新ニュース分析記事 • May 17Earnings Update: Here's Why Analysts Just Lifted Their C.Uyemura & Co.,Ltd. (TSE:4966) Price Target To JP¥24,300Last week saw the newest annual earnings release from C.Uyemura & Co.,Ltd. ( TSE:4966 ), an important milestone in the...Reported Earnings • May 15Full year 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2026 results: EPS: JP¥865 (down from JP¥873 in FY 2025). Revenue: JP¥91.8b (up 9.5% from FY 2025). Net income: JP¥13.9b (flat on FY 2025). Profit margin: 15% (down from 17% in FY 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) missed analyst estimates by 1.6%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 13C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026.お知らせ • May 09C.Uyemura & Co.,Ltd. to Report Fiscal Year 2026 Results on May 13, 2026C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2026 results on May 13, 2026New Risk • Mar 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Upcoming Dividend • Mar 23Upcoming dividend of JP¥290 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.3%).最新情報をもっと見るRecent updates分析記事 • May 17Earnings Update: Here's Why Analysts Just Lifted Their C.Uyemura & Co.,Ltd. (TSE:4966) Price Target To JP¥24,300Last week saw the newest annual earnings release from C.Uyemura & Co.,Ltd. ( TSE:4966 ), an important milestone in the...Reported Earnings • May 15Full year 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2026 results: EPS: JP¥865 (down from JP¥873 in FY 2025). Revenue: JP¥91.8b (up 9.5% from FY 2025). Net income: JP¥13.9b (flat on FY 2025). Profit margin: 15% (down from 17% in FY 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) missed analyst estimates by 1.6%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 13C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026.お知らせ • May 09C.Uyemura & Co.,Ltd. to Report Fiscal Year 2026 Results on May 13, 2026C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2026 results on May 13, 2026New Risk • Mar 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Upcoming Dividend • Mar 23Upcoming dividend of JP¥290 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.3%).Price Target Changed • Mar 14Price target increased by 18% to JP¥19,400Up from JP¥16,500, the current price target is an average from 2 analysts. New target price is 12% below last closing price of JP¥22,130. Stock is up 115% over the past year. The company is forecast to post earnings per share of JP¥908 for next year compared to JP¥873 last year.分析記事 • Feb 11C.UyemuraLtd's (TSE:4966) Upcoming Dividend Will Be Larger Than Last Year'sThe board of C.Uyemura & Co.,Ltd. ( TSE:4966 ) has announced that it will be paying its dividend of ¥290.00 on the 30th...Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: JP¥278 (vs JP¥260 in 3Q 2025)Third quarter 2026 results: EPS: JP¥278 (up from JP¥260 in 3Q 2025). Revenue: JP¥24.3b (up 7.5% from 3Q 2025). Net income: JP¥4.49b (up 7.1% from 3Q 2025). Profit margin: 19% (in line with 3Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 09C.Uyemura & Co.,Ltd. (TSE:4966) announces an Equity Buyback for 260,000 shares, representing 1.61% for ¥4,000 million.C.Uyemura & Co.,Ltd. (TSE:4966) announces a share repurchase program. Under the program, the company will repurchase up to 260,000 shares, representing 1.61% of its issued share capital (excluding treasury stock), for ¥4,000 million. The purpose of the program is to improve shareholder profits by implementing agile capital policies and improving capital efficiency in response to changes in the business environment. The program will run until September 30, 2026. As of January 31, 2026, the company had 16,137,861 shares in issue (excluding treasury stock) and 1,961,139 shares in treasury.分析記事 • Feb 03C.Uyemura & Co.,Ltd.'s (TSE:4966) 29% Price Boost Is Out Of Tune With EarningsC.Uyemura & Co.,Ltd. ( TSE:4966 ) shares have continued their recent momentum with a 29% gain in the last month alone...分析記事 • Jan 28Is Now An Opportune Moment To Examine C.Uyemura & Co.,Ltd. (TSE:4966)?C.Uyemura & Co.,Ltd. ( TSE:4966 ), is not the largest company out there, but it received a lot of attention from a...Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥17,290, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Chemicals industry in Japan. Total returns to shareholders of 186% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥27,734 per share.分析記事 • Jan 07We Like These Underlying Return On Capital Trends At C.UyemuraLtd (TSE:4966)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...お知らせ • Dec 27C.Uyemura & Co.,Ltd. to Report Q3, 2026 Results on Feb 09, 2026C.Uyemura & Co.,Ltd. announced that they will report Q3, 2026 results on Feb 09, 2026分析記事 • Dec 09Is C.UyemuraLtd (TSE:4966) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...分析記事 • Nov 24Is There An Opportunity With C.Uyemura & Co.,Ltd.'s (TSE:4966) 50% Undervaluation?Key Insights The projected fair value for C.UyemuraLtd is JP¥27,540 based on 2 Stage Free Cash Flow to Equity...Declared Dividend • Nov 12Dividend of JP¥280 announcedShareholders will receive a dividend of JP¥280. Ex-date: 30th March 2026 Payment date: 30th June 2026 Dividend yield will be 2.0%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (32% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 21% over the next 3 years, which should provide support to the dividend and adequate earnings cover.分析記事 • Nov 10C.Uyemura & Co.,Ltd. (TSE:4966) Investors Are Less Pessimistic Than ExpectedWith a median price-to-earnings (or "P/E") ratio of close to 14x in Japan, you could be forgiven for feeling...お知らせ • Sep 26C.Uyemura & Co.,Ltd. to Report Q2, 2026 Results on Nov 10, 2025C.Uyemura & Co.,Ltd. announced that they will report Q2, 2026 results on Nov 10, 2025分析記事 • Sep 05What Is C.Uyemura & Co.,Ltd.'s (TSE:4966) Share Price Doing?C.Uyemura & Co.,Ltd. ( TSE:4966 ), might not be a large cap stock, but it saw a double-digit share price rise of over...Price Target Changed • Aug 31Price target increased by 8.6% to JP¥15,750Up from JP¥14,500, the current price target is an average from 2 analysts. New target price is 50% above last closing price of JP¥10,490. Stock is down 1.9% over the past year. The company is forecast to post earnings per share of JP¥820 for next year compared to JP¥873 last year.Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥218 (vs JP¥233 in 1Q 2025)First quarter 2026 results: EPS: JP¥218 (down from JP¥233 in 1Q 2025). Revenue: JP¥20.1b (flat on 1Q 2025). Net income: JP¥3.52b (down 6.1% from 1Q 2025). Profit margin: 18% (down from 19% in 1Q 2025). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year and the company’s share price has also increased by 14% per year.分析記事 • Aug 06If EPS Growth Is Important To You, C.UyemuraLtd (TSE:4966) Presents An OpportunityIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...お知らせ • Jul 02C.Uyemura & Co.,Ltd. to Report Q1, 2026 Results on Aug 08, 2025C.Uyemura & Co.,Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025Major Estimate Revision • Jun 12Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from JP¥86.7b to JP¥84.5b. EPS estimate also fell from JP¥890 per share to JP¥777 per share. Net income forecast to shrink 11% next year vs 6.1% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥14,500 unchanged from last update. Share price was steady at JP¥8,800 over the past week.New Risk • May 25New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Reported Earnings • May 13Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥873 (up from JP¥673 in FY 2024). Revenue: JP¥83.8b (up 4.5% from FY 2024). Net income: JP¥14.1b (up 29% from FY 2024). Profit margin: 17% (up from 14% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 13% per year.分析記事 • May 13C.UyemuraLtd (TSE:4966) Is Doing The Right Things To Multiply Its Share PriceWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? One...お知らせ • May 12C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2025C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2025.分析記事 • Apr 29We Ran A Stock Scan For Earnings Growth And C.UyemuraLtd (TSE:4966) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...お知らせ • Apr 18C.Uyemura & Co.,Ltd. to Report Fiscal Year 2025 Results on May 12, 2025C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2025 results on May 12, 2025Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥8,340, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Chemicals industry in Japan. Total returns to shareholders of 48% over the past three years.分析記事 • Apr 06We Think C.UyemuraLtd (TSE:4966) Can Manage Its Debt With EaseLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Upcoming Dividend • Mar 21Upcoming dividend of JP¥280 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 30 June 2025. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).分析記事 • Mar 18C.Uyemura & Co.,Ltd.'s (TSE:4966) Shares May Have Run Too Fast Too SoonWith a median price-to-earnings (or "P/E") ratio of close to 13x in Japan, you could be forgiven for feeling...分析記事 • Feb 13C.UyemuraLtd (TSE:4966) Has Announced That It Will Be Increasing Its Dividend To ¥280.00C.Uyemura & Co.,Ltd.'s ( TSE:4966 ) periodic dividend will be increasing on the 30th of June to ¥280.00, with investors...Reported Earnings • Feb 12Third quarter 2025 earnings released: EPS: JP¥260 (vs JP¥198 in 3Q 2024)Third quarter 2025 results: EPS: JP¥260 (up from JP¥198 in 3Q 2024). Revenue: JP¥22.6b (up 9.2% from 3Q 2024). Net income: JP¥4.20b (up 31% from 3Q 2024). Profit margin: 19% (up from 16% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Jan 17Price target increased by 12% to JP¥14,450Up from JP¥12,850, the current price target is an average from 2 analysts. New target price is 33% above last closing price of JP¥10,870. Stock is up 1.7% over the past year. The company is forecast to post earnings per share of JP¥834 for next year compared to JP¥673 last year.Major Estimate Revision • Dec 04Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from JP¥736 to JP¥837. Revenue forecast steady at JP¥83.0b. Net income forecast to shrink 4.5% next year vs 13% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥11,850 unchanged from last update. Share price rose 2.1% to JP¥11,060 over the past week.分析記事 • Nov 28Unpleasant Surprises Could Be In Store For C.Uyemura & Co.,Ltd.'s (TSE:4966) SharesThere wouldn't be many who think C.Uyemura & Co.,Ltd.'s ( TSE:4966 ) price-to-earnings (or "P/E") ratio of 12.6x is...お知らせ • Nov 28C.Uyemura & Co.,Ltd. to Report Q3, 2025 Results on Feb 10, 2025C.Uyemura & Co.,Ltd. announced that they will report Q3, 2025 results on Feb 10, 2025Buy Or Sell Opportunity • Nov 21Now 20% undervaluedOver the last 90 days, the stock has risen 5.5% to JP¥11,140. The fair value is estimated to be JP¥13,973, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.7% over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 4.0% per annum over the same time period.Declared Dividend • Nov 13Dividend of JP¥200 announcedShareholders will receive a dividend of JP¥200. Ex-date: 28th March 2025 Payment date: 30th June 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (24% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 6.2% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥12,170, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 148% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥13,942 per share.分析記事 • Oct 26Is There An Opportunity With C.Uyemura & Co.,Ltd.'s (TSE:4966) 28% Undervaluation?Key Insights C.UyemuraLtd's estimated fair value is JP¥14,008 based on 2 Stage Free Cash Flow to Equity Current share...Buy Or Sell Opportunity • Oct 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.9% to JP¥10,980. The fair value is estimated to be JP¥13,981, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 8.2% per annum over the same time period.Buy Or Sell Opportunity • Sep 24Now 21% undervaluedOver the last 90 days, the stock has risen 2.2% to JP¥11,140. The fair value is estimated to be JP¥14,025, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 8.2% per annum over the same time period.分析記事 • Sep 05C.UyemuraLtd (TSE:4966) Is Experiencing Growth In Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...お知らせ • Aug 28C.Uyemura & Co.,Ltd. to Report Q2, 2025 Results on Nov 11, 2024C.Uyemura & Co.,Ltd. announced that they will report Q2, 2025 results on Nov 11, 2024分析記事 • Aug 05C.Uyemura & Co.,Ltd. (TSE:4966) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyC.Uyemura & Co.,Ltd. ( TSE:4966 ) shareholders won't be pleased to see that the share price has had a very rough month...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to JP¥8,060, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥9,809 per share.分析記事 • Aug 02Is It Too Late To Consider Buying C.Uyemura & Co.,Ltd. (TSE:4966)?While C.Uyemura & Co.,Ltd. ( TSE:4966 ) might not have the largest market cap around , it saw significant share price...New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Jul 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 3.3% to JP¥10,730. The fair value is estimated to be JP¥8,654, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 2.8% to JP¥10,790. The fair value is estimated to be JP¥8,600, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.分析記事 • Jun 27Are C.Uyemura & Co.,Ltd. (TSE:4966) Investors Paying Above The Intrinsic Value?Key Insights Using the 2 Stage Free Cash Flow to Equity, C.UyemuraLtd fair value estimate is JP¥8,588 C.UyemuraLtd is...Buy Or Sell Opportunity • Jun 20Now 24% overvaluedOver the last 90 days, the stock has fallen 1.5% to JP¥10,650. The fair value is estimated to be JP¥8,563, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.分析記事 • Jun 14C.UyemuraLtd (TSE:4966) Has A Pretty Healthy Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Jun 08C.Uyemura & Co.,Ltd. to Report Q1, 2025 Results on Aug 08, 2024C.Uyemura & Co.,Ltd. announced that they will report Q1, 2025 results on Aug 08, 2024Buy Or Sell Opportunity • May 30Now 20% overvaluedOver the last 90 days, the stock has fallen 15% to JP¥10,250. The fair value is estimated to be JP¥8,534, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. Revenue is forecast to grow by 9.2% in 2 years. Earnings are forecast to grow by 12% in the next 2 years.Reported Earnings • May 12Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥673 (up from JP¥637 in FY 2023). Revenue: JP¥80.3b (down 6.4% from FY 2023). Net income: JP¥10.9b (up 3.6% from FY 2023). Profit margin: 14% (up from 12% in FY 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.Buy Or Sell Opportunity • May 12Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.1% to JP¥9,810. The fair value is estimated to be JP¥12,378, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. Revenue is forecast to grow by 9.2% in 2 years. Earnings are forecast to grow by 12% in the next 2 years.お知らせ • May 12C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2024C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2024.分析記事 • Apr 18The Price Is Right For C.Uyemura & Co.,Ltd. (TSE:4966)With a price-to-earnings (or "P/E") ratio of 17.5x C.Uyemura & Co.,Ltd. ( TSE:4966 ) may be sending bearish signals at...Buy Or Sell Opportunity • Apr 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to JP¥9,730. The fair value is estimated to be JP¥12,326, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 9.9% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.お知らせ • Mar 28C.Uyemura & Co.,Ltd. to Report Fiscal Year 2024 Results on May 10, 2024C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2024 results on May 10, 2024Upcoming Dividend • Mar 21Upcoming dividend of JP¥180 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.2%). Lower than average of industry peers (2.1%).分析記事 • Feb 29Slowing Rates Of Return At C.UyemuraLtd (TSE:4966) Leave Little Room For ExcitementWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥198 (vs JP¥177 in 3Q 2023)Third quarter 2024 results: EPS: JP¥198 (up from JP¥177 in 3Q 2023). Revenue: JP¥20.7b (down 9.5% from 3Q 2023). Net income: JP¥3.20b (up 9.6% from 3Q 2023). Profit margin: 16% (up from 13% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Dec 28C.Uyemura & Co.,Ltd. to Report Q3, 2024 Results on Feb 09, 2024C.Uyemura & Co.,Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024Major Estimate Revision • Dec 02Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from JP¥76.8b to JP¥78.4b. EPS estimate increased from JP¥476 to JP¥529 per share. Net income forecast to grow 8.3% next year vs 13% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥10,000 unchanged from last update. Share price rose 4.4% to JP¥10,650 over the past week.Buying Opportunity • Nov 17Now 21% undervaluedOver the last 90 days, the stock is up 11%. The fair value is estimated to be JP¥12,214, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 4.8% in 2 years. Earnings is forecast to grow by 18% in the next 2 years.Reported Earnings • Nov 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: EPS: JP¥133 (down from JP¥140 in 2Q 2023). Revenue: JP¥19.7b (down 10% from 2Q 2023). Net income: JP¥2.16b (down 6.6% from 2Q 2023). Profit margin: 11% (in line with 2Q 2023). Revenue exceeded analyst estimates by 4.8%. Earnings per share (EPS) also surpassed analyst estimates by 5.9%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Sep 23C.Uyemura & Co.,Ltd. to Report Q2, 2024 Results on Nov 13, 2023C.Uyemura & Co.,Ltd. announced that they will report Q2, 2024 results on Nov 13, 2023Buying Opportunity • Sep 11Now 20% undervaluedOver the last 90 days, the stock is up 28%. The fair value is estimated to be JP¥12,189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 23%. Revenue is forecast to grow by 0.4% in 2 years. Earnings is forecast to grow by 11% in the next 2 years.Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥115 (vs JP¥218 in 1Q 2023)First quarter 2024 results: EPS: JP¥115 (down from JP¥218 in 1Q 2023). Revenue: JP¥17.5b (down 13% from 1Q 2023). Net income: JP¥1.90b (down 48% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jun 28C.Uyemura & Co.,Ltd. to Report Q1, 2024 Results on Aug 09, 2023C.Uyemura & Co.,Ltd. announced that they will report Q1, 2024 results on Aug 09, 2023New Risk • Jun 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Reported Earnings • May 16Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: JP¥637 (up from JP¥560 in FY 2022). Revenue: JP¥85.7b (up 19% from FY 2022). Net income: JP¥10.5b (up 8.9% from FY 2022). Profit margin: 12% (down from 13% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates by 7.5%. Revenue is forecast to stay flat during the next 2 years compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 28% per year and the company’s share price has also increased by 28% per year.お知らせ • May 14C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2023C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥180 per share at 1.4% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 9.7% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.8%).Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥177 (vs JP¥160 in 3Q 2022)Third quarter 2023 results: EPS: JP¥177 (up from JP¥160 in 3Q 2022). Revenue: JP¥22.8b (up 23% from 3Q 2022). Net income: JP¥2.92b (up 5.7% from 3Q 2022). Profit margin: 13% (down from 15% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.お知らせ • Dec 04C.Uyemura & Co.,Ltd. to Report Q3, 2023 Results on Feb 10, 2023C.Uyemura & Co.,Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 8 highly experienced directors. No independent directors (9 non-independent directors). External Director Akihiko Takahashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 13Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: JP¥140 (down from JP¥141 in 2Q 2022). Revenue: JP¥21.9b (up 27% from 2Q 2022). Net income: JP¥2.32b (down 4.5% from 2Q 2022). Profit margin: 11% (down from 14% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 28C.Uyemura & Co.,Ltd. to Report Q2, 2023 Results on Nov 11, 2022C.Uyemura & Co.,Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022Reported Earnings • Aug 09First quarter 2023 earnings released: EPS: JP¥218 (vs JP¥121 in 1Q 2022)First quarter 2023 results: EPS: JP¥218 (up from JP¥121 in 1Q 2022). Revenue: JP¥20.2b (up 28% from 1Q 2022). Net income: JP¥3.66b (up 73% from 1Q 2022). Profit margin: 18% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 5.6%, compared to a 9.3% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 32% per year.お知らせ • Jun 30C.Uyemura & Co.,Ltd. to Report Q1, 2023 Results on Aug 08, 2022C.Uyemura & Co.,Ltd. announced that they will report Q1, 2023 results on Aug 08, 2022Major Estimate Revision • Jun 04Consensus EPS estimates increase by 25%The consensus outlook for earnings per share (EPS) in 2023 has improved. 2023 revenue forecast increased from JP¥75.2b to JP¥78.5b. EPS estimate increased from JP¥604 to JP¥754 per share. Net income forecast to grow 34% next year vs 5.9% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥7,224 unchanged from last update. Share price rose 4.4% to JP¥7,340 over the past week.Reported Earnings • May 16Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: JP¥560 (up from JP¥403 in FY 2021). Revenue: JP¥72.3b (up 29% from FY 2021). Net income: JP¥9.68b (up 36% from FY 2021). Profit margin: 13% (in line with FY 2021). Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 2.9%. Over the next year, revenue is forecast to grow 4.0%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year.お知らせ • May 15C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2022C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2022.Price Target Changed • Apr 27Price target increased to JP¥7,224Up from JP¥4,650, the current price target is an average from 3 analysts. New target price is 27% above last closing price of JP¥5,700. Stock is up 55% over the past year. The company is forecast to post earnings per share of JP¥577 for next year compared to JP¥403 last year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 8 highly experienced directors. No independent directors (9 non-independent directors). External Director Akihiko Takahashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Apr 08C.Uyemura & Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥130 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).株主還元4966JP ChemicalsJP 市場7D-8.8%-4.6%-3.1%1Y156.1%47.8%38.2%株主還元を見る業界別リターン: 4966過去 1 年間で47.8 % の収益を上げたJP Chemicals業界を上回りました。リターン対市場: 4966過去 1 年間で38.2 % の収益を上げたJP市場を上回りました。価格変動Is 4966's price volatile compared to industry and market?4966 volatility4966 Average Weekly Movement7.2%Chemicals Industry Average Movement6.0%Market Average Movement5.0%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.5%安定した株価: 4966の株価は、 JP市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 4966の weekly volatility ( 7% ) は過去 1 年間安定していますが、依然としてJPの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト18481,552Hiroya Uemurawww.uyemura.co.jp上村商会は、子会社とともに、日本、台湾、中国および海外で表面処理薬品・機械の研究・開発・製造・販売を行っている。表面処理材料事業、表面処理機械事業、めっき加工事業、不動産賃貸事業、その他事業を行っている。プリント配線板・アルミ磁気ディスク用めっき薬品・装置、工業薬品、非鉄金属用めっき薬品・装置を提供。また、パッケージ基板、リジッド、フレキシブルプリント配線板などの電子回路基板、めっき装置、めっき液管理システム、ロジックデバイス、メモリーデバイスなどの半導体、コネクター、受動素子、パワーデバイスなどの電気部品、前処理、複合めっき、ニッケルめっき、めっき液管理システムなどの機能めっきを提供している。また、銅めっき、最終仕上げめっき、無電解めっき、ハードディスクメディア用Ni-Pめっきプロセス、バンプ形成用電解めっきプロセス、化学的前処理・後処理・剥離剤、クロムめっき、亜鉛めっき、錫めっき、錫合金めっき、金めっき、銀めっき、パラジウムめっき、固体・液体バフ研磨、バレル研磨などの研磨化合物溶液、研磨装置、表面処理システムなどを提供している。また、オフィスビル、マンション、工場用地の賃貸も行っている。上村商会は1848年に設立され、大阪に本社を置く。もっと見るC.Uyemura & Co.,Ltd. 基礎のまとめC.UyemuraLtd の収益と売上を時価総額と比較するとどうか。4966 基礎統計学時価総額JP¥367.14b収益（TTM）JP¥13.95b売上高(TTM)JP¥91.78b27.1xPER（株価収益率4.1xP/Sレシオ4966 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計4966 損益計算書（TTM）収益JP¥91.78b売上原価JP¥55.80b売上総利益JP¥35.98bその他の費用JP¥22.04b収益JP¥13.95b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）864.18グロス・マージン39.20%純利益率15.19%有利子負債／自己資本比率0.3%4966 の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.2%現在の配当利回り31%配当性向4966 配当は確実ですか？4966 配当履歴とベンチマークを見る4966 、いつまでに購入すれば配当金を受け取れますか？C.UyemuraLtd 配当日配当落ち日Mar 30 2026配当支払日Jun 29 2026配当落ちまでの日数53 days配当支払日までの日数38 days4966 配当は確実ですか？4966 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 16:01終値2026/05/21 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋C.Uyemura & Co.,Ltd. 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。5 アナリスト機関Shiho NamikawaDaiwa Securities Co. Ltd.Wei LiuHaitong International Research LimitedKoichi HariyaIchiyoshi Research Institute Inc.2 その他のアナリストを表示
分析記事 • May 17Earnings Update: Here's Why Analysts Just Lifted Their C.Uyemura & Co.,Ltd. (TSE:4966) Price Target To JP¥24,300Last week saw the newest annual earnings release from C.Uyemura & Co.,Ltd. ( TSE:4966 ), an important milestone in the...
Reported Earnings • May 15Full year 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2026 results: EPS: JP¥865 (down from JP¥873 in FY 2025). Revenue: JP¥91.8b (up 9.5% from FY 2025). Net income: JP¥13.9b (flat on FY 2025). Profit margin: 15% (down from 17% in FY 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) missed analyst estimates by 1.6%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 13C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026.
お知らせ • May 09C.Uyemura & Co.,Ltd. to Report Fiscal Year 2026 Results on May 13, 2026C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2026 results on May 13, 2026
New Risk • Mar 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥290 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.3%).
分析記事 • May 17Earnings Update: Here's Why Analysts Just Lifted Their C.Uyemura & Co.,Ltd. (TSE:4966) Price Target To JP¥24,300Last week saw the newest annual earnings release from C.Uyemura & Co.,Ltd. ( TSE:4966 ), an important milestone in the...
Reported Earnings • May 15Full year 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2026 results: EPS: JP¥865 (down from JP¥873 in FY 2025). Revenue: JP¥91.8b (up 9.5% from FY 2025). Net income: JP¥13.9b (flat on FY 2025). Profit margin: 15% (down from 17% in FY 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) missed analyst estimates by 1.6%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 13C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 26, 2026.
お知らせ • May 09C.Uyemura & Co.,Ltd. to Report Fiscal Year 2026 Results on May 13, 2026C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2026 results on May 13, 2026
New Risk • Mar 31New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥290 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.3%).
Price Target Changed • Mar 14Price target increased by 18% to JP¥19,400Up from JP¥16,500, the current price target is an average from 2 analysts. New target price is 12% below last closing price of JP¥22,130. Stock is up 115% over the past year. The company is forecast to post earnings per share of JP¥908 for next year compared to JP¥873 last year.
分析記事 • Feb 11C.UyemuraLtd's (TSE:4966) Upcoming Dividend Will Be Larger Than Last Year'sThe board of C.Uyemura & Co.,Ltd. ( TSE:4966 ) has announced that it will be paying its dividend of ¥290.00 on the 30th...
Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: JP¥278 (vs JP¥260 in 3Q 2025)Third quarter 2026 results: EPS: JP¥278 (up from JP¥260 in 3Q 2025). Revenue: JP¥24.3b (up 7.5% from 3Q 2025). Net income: JP¥4.49b (up 7.1% from 3Q 2025). Profit margin: 19% (in line with 3Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 09C.Uyemura & Co.,Ltd. (TSE:4966) announces an Equity Buyback for 260,000 shares, representing 1.61% for ¥4,000 million.C.Uyemura & Co.,Ltd. (TSE:4966) announces a share repurchase program. Under the program, the company will repurchase up to 260,000 shares, representing 1.61% of its issued share capital (excluding treasury stock), for ¥4,000 million. The purpose of the program is to improve shareholder profits by implementing agile capital policies and improving capital efficiency in response to changes in the business environment. The program will run until September 30, 2026. As of January 31, 2026, the company had 16,137,861 shares in issue (excluding treasury stock) and 1,961,139 shares in treasury.
分析記事 • Feb 03C.Uyemura & Co.,Ltd.'s (TSE:4966) 29% Price Boost Is Out Of Tune With EarningsC.Uyemura & Co.,Ltd. ( TSE:4966 ) shares have continued their recent momentum with a 29% gain in the last month alone...
分析記事 • Jan 28Is Now An Opportune Moment To Examine C.Uyemura & Co.,Ltd. (TSE:4966)?C.Uyemura & Co.,Ltd. ( TSE:4966 ), is not the largest company out there, but it received a lot of attention from a...
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥17,290, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 14x in the Chemicals industry in Japan. Total returns to shareholders of 186% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥27,734 per share.
分析記事 • Jan 07We Like These Underlying Return On Capital Trends At C.UyemuraLtd (TSE:4966)If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
お知らせ • Dec 27C.Uyemura & Co.,Ltd. to Report Q3, 2026 Results on Feb 09, 2026C.Uyemura & Co.,Ltd. announced that they will report Q3, 2026 results on Feb 09, 2026
分析記事 • Dec 09Is C.UyemuraLtd (TSE:4966) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
分析記事 • Nov 24Is There An Opportunity With C.Uyemura & Co.,Ltd.'s (TSE:4966) 50% Undervaluation?Key Insights The projected fair value for C.UyemuraLtd is JP¥27,540 based on 2 Stage Free Cash Flow to Equity...
Declared Dividend • Nov 12Dividend of JP¥280 announcedShareholders will receive a dividend of JP¥280. Ex-date: 30th March 2026 Payment date: 30th June 2026 Dividend yield will be 2.0%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (32% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 21% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
分析記事 • Nov 10C.Uyemura & Co.,Ltd. (TSE:4966) Investors Are Less Pessimistic Than ExpectedWith a median price-to-earnings (or "P/E") ratio of close to 14x in Japan, you could be forgiven for feeling...
お知らせ • Sep 26C.Uyemura & Co.,Ltd. to Report Q2, 2026 Results on Nov 10, 2025C.Uyemura & Co.,Ltd. announced that they will report Q2, 2026 results on Nov 10, 2025
分析記事 • Sep 05What Is C.Uyemura & Co.,Ltd.'s (TSE:4966) Share Price Doing?C.Uyemura & Co.,Ltd. ( TSE:4966 ), might not be a large cap stock, but it saw a double-digit share price rise of over...
Price Target Changed • Aug 31Price target increased by 8.6% to JP¥15,750Up from JP¥14,500, the current price target is an average from 2 analysts. New target price is 50% above last closing price of JP¥10,490. Stock is down 1.9% over the past year. The company is forecast to post earnings per share of JP¥820 for next year compared to JP¥873 last year.
Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥218 (vs JP¥233 in 1Q 2025)First quarter 2026 results: EPS: JP¥218 (down from JP¥233 in 1Q 2025). Revenue: JP¥20.1b (flat on 1Q 2025). Net income: JP¥3.52b (down 6.1% from 1Q 2025). Profit margin: 18% (down from 19% in 1Q 2025). Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year and the company’s share price has also increased by 14% per year.
分析記事 • Aug 06If EPS Growth Is Important To You, C.UyemuraLtd (TSE:4966) Presents An OpportunityIt's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
お知らせ • Jul 02C.Uyemura & Co.,Ltd. to Report Q1, 2026 Results on Aug 08, 2025C.Uyemura & Co.,Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
Major Estimate Revision • Jun 12Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from JP¥86.7b to JP¥84.5b. EPS estimate also fell from JP¥890 per share to JP¥777 per share. Net income forecast to shrink 11% next year vs 6.1% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥14,500 unchanged from last update. Share price was steady at JP¥8,800 over the past week.
New Risk • May 25New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Reported Earnings • May 13Full year 2025 earnings: Revenues and EPS in line with analyst expectationsFull year 2025 results: EPS: JP¥873 (up from JP¥673 in FY 2024). Revenue: JP¥83.8b (up 4.5% from FY 2024). Net income: JP¥14.1b (up 29% from FY 2024). Profit margin: 17% (up from 14% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 13% per year.
分析記事 • May 13C.UyemuraLtd (TSE:4966) Is Doing The Right Things To Multiply Its Share PriceWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
お知らせ • May 12C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2025C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2025.
分析記事 • Apr 29We Ran A Stock Scan For Earnings Growth And C.UyemuraLtd (TSE:4966) Passed With EaseFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
お知らせ • Apr 18C.Uyemura & Co.,Ltd. to Report Fiscal Year 2025 Results on May 12, 2025C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2025 results on May 12, 2025
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥8,340, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 10x in the Chemicals industry in Japan. Total returns to shareholders of 48% over the past three years.
分析記事 • Apr 06We Think C.UyemuraLtd (TSE:4966) Can Manage Its Debt With EaseLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Upcoming Dividend • Mar 21Upcoming dividend of JP¥280 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 30 June 2025. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).
分析記事 • Mar 18C.Uyemura & Co.,Ltd.'s (TSE:4966) Shares May Have Run Too Fast Too SoonWith a median price-to-earnings (or "P/E") ratio of close to 13x in Japan, you could be forgiven for feeling...
分析記事 • Feb 13C.UyemuraLtd (TSE:4966) Has Announced That It Will Be Increasing Its Dividend To ¥280.00C.Uyemura & Co.,Ltd.'s ( TSE:4966 ) periodic dividend will be increasing on the 30th of June to ¥280.00, with investors...
Reported Earnings • Feb 12Third quarter 2025 earnings released: EPS: JP¥260 (vs JP¥198 in 3Q 2024)Third quarter 2025 results: EPS: JP¥260 (up from JP¥198 in 3Q 2024). Revenue: JP¥22.6b (up 9.2% from 3Q 2024). Net income: JP¥4.20b (up 31% from 3Q 2024). Profit margin: 19% (up from 16% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Jan 17Price target increased by 12% to JP¥14,450Up from JP¥12,850, the current price target is an average from 2 analysts. New target price is 33% above last closing price of JP¥10,870. Stock is up 1.7% over the past year. The company is forecast to post earnings per share of JP¥834 for next year compared to JP¥673 last year.
Major Estimate Revision • Dec 04Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from JP¥736 to JP¥837. Revenue forecast steady at JP¥83.0b. Net income forecast to shrink 4.5% next year vs 13% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥11,850 unchanged from last update. Share price rose 2.1% to JP¥11,060 over the past week.
分析記事 • Nov 28Unpleasant Surprises Could Be In Store For C.Uyemura & Co.,Ltd.'s (TSE:4966) SharesThere wouldn't be many who think C.Uyemura & Co.,Ltd.'s ( TSE:4966 ) price-to-earnings (or "P/E") ratio of 12.6x is...
お知らせ • Nov 28C.Uyemura & Co.,Ltd. to Report Q3, 2025 Results on Feb 10, 2025C.Uyemura & Co.,Ltd. announced that they will report Q3, 2025 results on Feb 10, 2025
Buy Or Sell Opportunity • Nov 21Now 20% undervaluedOver the last 90 days, the stock has risen 5.5% to JP¥11,140. The fair value is estimated to be JP¥13,973, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.7% over the last 3 years. Earnings per share has grown by 11%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 4.0% per annum over the same time period.
Declared Dividend • Nov 13Dividend of JP¥200 announcedShareholders will receive a dividend of JP¥200. Ex-date: 28th March 2025 Payment date: 30th June 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (24% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 6.2% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to JP¥12,170, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 148% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥13,942 per share.
分析記事 • Oct 26Is There An Opportunity With C.Uyemura & Co.,Ltd.'s (TSE:4966) 28% Undervaluation?Key Insights C.UyemuraLtd's estimated fair value is JP¥14,008 based on 2 Stage Free Cash Flow to Equity Current share...
Buy Or Sell Opportunity • Oct 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.9% to JP¥10,980. The fair value is estimated to be JP¥13,981, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 8.2% per annum over the same time period.
Buy Or Sell Opportunity • Sep 24Now 21% undervaluedOver the last 90 days, the stock has risen 2.2% to JP¥11,140. The fair value is estimated to be JP¥14,025, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 5.7% per annum. Earnings are also forecast to grow by 8.2% per annum over the same time period.
分析記事 • Sep 05C.UyemuraLtd (TSE:4966) Is Experiencing Growth In Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
お知らせ • Aug 28C.Uyemura & Co.,Ltd. to Report Q2, 2025 Results on Nov 11, 2024C.Uyemura & Co.,Ltd. announced that they will report Q2, 2025 results on Nov 11, 2024
分析記事 • Aug 05C.Uyemura & Co.,Ltd. (TSE:4966) Shares May Have Slumped 25% But Getting In Cheap Is Still UnlikelyC.Uyemura & Co.,Ltd. ( TSE:4966 ) shareholders won't be pleased to see that the share price has had a very rough month...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to JP¥8,060, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥9,809 per share.
分析記事 • Aug 02Is It Too Late To Consider Buying C.Uyemura & Co.,Ltd. (TSE:4966)?While C.Uyemura & Co.,Ltd. ( TSE:4966 ) might not have the largest market cap around , it saw significant share price...
New Risk • Aug 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Jul 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 3.3% to JP¥10,730. The fair value is estimated to be JP¥8,654, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.
Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 2.8% to JP¥10,790. The fair value is estimated to be JP¥8,600, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.
分析記事 • Jun 27Are C.Uyemura & Co.,Ltd. (TSE:4966) Investors Paying Above The Intrinsic Value?Key Insights Using the 2 Stage Free Cash Flow to Equity, C.UyemuraLtd fair value estimate is JP¥8,588 C.UyemuraLtd is...
Buy Or Sell Opportunity • Jun 20Now 24% overvaluedOver the last 90 days, the stock has fallen 1.5% to JP¥10,650. The fair value is estimated to be JP¥8,563, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings are also forecast to grow by 2.6% per annum over the same time period.
分析記事 • Jun 14C.UyemuraLtd (TSE:4966) Has A Pretty Healthy Balance SheetHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Jun 08C.Uyemura & Co.,Ltd. to Report Q1, 2025 Results on Aug 08, 2024C.Uyemura & Co.,Ltd. announced that they will report Q1, 2025 results on Aug 08, 2024
Buy Or Sell Opportunity • May 30Now 20% overvaluedOver the last 90 days, the stock has fallen 15% to JP¥10,250. The fair value is estimated to be JP¥8,534, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. Revenue is forecast to grow by 9.2% in 2 years. Earnings are forecast to grow by 12% in the next 2 years.
Reported Earnings • May 12Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥673 (up from JP¥637 in FY 2023). Revenue: JP¥80.3b (down 6.4% from FY 2023). Net income: JP¥10.9b (up 3.6% from FY 2023). Profit margin: 14% (up from 12% in FY 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 4.4% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
Buy Or Sell Opportunity • May 12Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.1% to JP¥9,810. The fair value is estimated to be JP¥12,378, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 9.5%. Revenue is forecast to grow by 9.2% in 2 years. Earnings are forecast to grow by 12% in the next 2 years.
お知らせ • May 12C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2024C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 27, 2024.
分析記事 • Apr 18The Price Is Right For C.Uyemura & Co.,Ltd. (TSE:4966)With a price-to-earnings (or "P/E") ratio of 17.5x C.Uyemura & Co.,Ltd. ( TSE:4966 ) may be sending bearish signals at...
Buy Or Sell Opportunity • Apr 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to JP¥9,730. The fair value is estimated to be JP¥12,326, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 9.9% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.
お知らせ • Mar 28C.Uyemura & Co.,Ltd. to Report Fiscal Year 2024 Results on May 10, 2024C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2024 results on May 10, 2024
Upcoming Dividend • Mar 21Upcoming dividend of JP¥180 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of Japanese dividend payers (3.2%). Lower than average of industry peers (2.1%).
分析記事 • Feb 29Slowing Rates Of Return At C.UyemuraLtd (TSE:4966) Leave Little Room For ExcitementWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥198 (vs JP¥177 in 3Q 2023)Third quarter 2024 results: EPS: JP¥198 (up from JP¥177 in 3Q 2023). Revenue: JP¥20.7b (down 9.5% from 3Q 2023). Net income: JP¥3.20b (up 9.6% from 3Q 2023). Profit margin: 16% (up from 13% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Dec 28C.Uyemura & Co.,Ltd. to Report Q3, 2024 Results on Feb 09, 2024C.Uyemura & Co.,Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024
Major Estimate Revision • Dec 02Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from JP¥76.8b to JP¥78.4b. EPS estimate increased from JP¥476 to JP¥529 per share. Net income forecast to grow 8.3% next year vs 13% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥10,000 unchanged from last update. Share price rose 4.4% to JP¥10,650 over the past week.
Buying Opportunity • Nov 17Now 21% undervaluedOver the last 90 days, the stock is up 11%. The fair value is estimated to be JP¥12,214, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 4.8% in 2 years. Earnings is forecast to grow by 18% in the next 2 years.
Reported Earnings • Nov 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: EPS: JP¥133 (down from JP¥140 in 2Q 2023). Revenue: JP¥19.7b (down 10% from 2Q 2023). Net income: JP¥2.16b (down 6.6% from 2Q 2023). Profit margin: 11% (in line with 2Q 2023). Revenue exceeded analyst estimates by 4.8%. Earnings per share (EPS) also surpassed analyst estimates by 5.9%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Sep 23C.Uyemura & Co.,Ltd. to Report Q2, 2024 Results on Nov 13, 2023C.Uyemura & Co.,Ltd. announced that they will report Q2, 2024 results on Nov 13, 2023
Buying Opportunity • Sep 11Now 20% undervaluedOver the last 90 days, the stock is up 28%. The fair value is estimated to be JP¥12,189, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 23%. Revenue is forecast to grow by 0.4% in 2 years. Earnings is forecast to grow by 11% in the next 2 years.
Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥115 (vs JP¥218 in 1Q 2023)First quarter 2024 results: EPS: JP¥115 (down from JP¥218 in 1Q 2023). Revenue: JP¥17.5b (down 13% from 1Q 2023). Net income: JP¥1.90b (down 48% from 1Q 2023). Profit margin: 11% (down from 18% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jun 28C.Uyemura & Co.,Ltd. to Report Q1, 2024 Results on Aug 09, 2023C.Uyemura & Co.,Ltd. announced that they will report Q1, 2024 results on Aug 09, 2023
New Risk • Jun 11New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Reported Earnings • May 16Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2023 results: EPS: JP¥637 (up from JP¥560 in FY 2022). Revenue: JP¥85.7b (up 19% from FY 2022). Net income: JP¥10.5b (up 8.9% from FY 2022). Profit margin: 12% (down from 13% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates by 7.5%. Revenue is forecast to stay flat during the next 2 years compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 28% per year and the company’s share price has also increased by 28% per year.
お知らせ • May 14C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2023C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥180 per share at 1.4% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 9.7% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.8%).
Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥177 (vs JP¥160 in 3Q 2022)Third quarter 2023 results: EPS: JP¥177 (up from JP¥160 in 3Q 2022). Revenue: JP¥22.8b (up 23% from 3Q 2022). Net income: JP¥2.92b (up 5.7% from 3Q 2022). Profit margin: 13% (down from 15% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
お知らせ • Dec 04C.Uyemura & Co.,Ltd. to Report Q3, 2023 Results on Feb 10, 2023C.Uyemura & Co.,Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 8 highly experienced directors. No independent directors (9 non-independent directors). External Director Akihiko Takahashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 13Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2023 results: EPS: JP¥140 (down from JP¥141 in 2Q 2022). Revenue: JP¥21.9b (up 27% from 2Q 2022). Net income: JP¥2.32b (down 4.5% from 2Q 2022). Profit margin: 11% (down from 14% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 7.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 28C.Uyemura & Co.,Ltd. to Report Q2, 2023 Results on Nov 11, 2022C.Uyemura & Co.,Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022
Reported Earnings • Aug 09First quarter 2023 earnings released: EPS: JP¥218 (vs JP¥121 in 1Q 2022)First quarter 2023 results: EPS: JP¥218 (up from JP¥121 in 1Q 2022). Revenue: JP¥20.2b (up 28% from 1Q 2022). Net income: JP¥3.66b (up 73% from 1Q 2022). Profit margin: 18% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 5.6%, compared to a 9.3% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 32% per year.
お知らせ • Jun 30C.Uyemura & Co.,Ltd. to Report Q1, 2023 Results on Aug 08, 2022C.Uyemura & Co.,Ltd. announced that they will report Q1, 2023 results on Aug 08, 2022
Major Estimate Revision • Jun 04Consensus EPS estimates increase by 25%The consensus outlook for earnings per share (EPS) in 2023 has improved. 2023 revenue forecast increased from JP¥75.2b to JP¥78.5b. EPS estimate increased from JP¥604 to JP¥754 per share. Net income forecast to grow 34% next year vs 5.9% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥7,224 unchanged from last update. Share price rose 4.4% to JP¥7,340 over the past week.
Reported Earnings • May 16Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: JP¥560 (up from JP¥403 in FY 2021). Revenue: JP¥72.3b (up 29% from FY 2021). Net income: JP¥9.68b (up 36% from FY 2021). Profit margin: 13% (in line with FY 2021). Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 2.9%. Over the next year, revenue is forecast to grow 4.0%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 24% per year and the company’s share price has also increased by 24% per year.
お知らせ • May 15C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2022C.Uyemura & Co.,Ltd., Annual General Meeting, Jun 29, 2022.
Price Target Changed • Apr 27Price target increased to JP¥7,224Up from JP¥4,650, the current price target is an average from 3 analysts. New target price is 27% above last closing price of JP¥5,700. Stock is up 55% over the past year. The company is forecast to post earnings per share of JP¥577 for next year compared to JP¥403 last year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 8 highly experienced directors. No independent directors (9 non-independent directors). External Director Akihiko Takahashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Apr 08C.Uyemura & Co.,Ltd. to Report Fiscal Year 2022 Results on May 13, 2022C.Uyemura & Co.,Ltd. announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥130 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
